Brodersen J, Schwartz LM, Heneghan C, O’Sullivan JW, Aronson JK, Woloshin S. Overdiagnosis: what it is and what it isn’t. BMJ Evidence-Based Medicine. 2018; 23(1): 1. DOI: https://doi.org/10.1136/ebmed-2017-110886 

Chalmers K, Pearson SA, Elshaug AG. Quantifying low-value care: a patient-centric versus service-centric lens. BMJ Quality & Safety. 2017; 26(10): 855–8. DOI: https://doi.org/10.1136/bmjqs-2017-006678 

Lyu H, Xu T, Brotman D, et al. Overtreatment in the United States. PLoS One. 2017; 12(9): e0181970–e. DOI: https://doi.org/10.1371/journal.pone.0181970 

Morgan DJ, Dhruva SS, Wright SM, Korenstein D. 2016 Update on Medical Overuse: A Systematic Review. JAMA Intern Med. 2016; 176(11): 1687–92. DOI: https://doi.org/10.1001/jamainternmed.2016.5381 

Research on medical overuse: Overdiagnosis and overtreatment in family medicine and primary care. European Journal of General Practice. 2016; 22(4): 278–86. DOI: https://doi.org/10.1080/13814788.2016.1216542 

O’Sullivan JW, Albasri A, Nicholson BD, et al. Overtesting and undertesting in primary care: a systematic review and meta-analysis. BMJ Open. 2018; 8(2): e018557. DOI: https://doi.org/10.1136/bmjopen-2017-018557 

Muche-Borowski C, Abiry D, Wagner H-O, et al. Protection against the overuse and underuse of health care – methodological considerations for establishing prioritization criteria and recommendations in general practice. BMC Health Services Research. 2018; 18(1): 768. DOI: https://doi.org/10.1186/s12913-018-3569-9 

Eikelboom JW, Hankey GJ. Is there really misuse and abuse of dabigatran? Med J Aust. 2013; 198(7): 358–9. DOI: https://doi.org/10.5694/mja12.11642 

Jones NR, Hobbs FDR, Taylor CJ. Underuse of anticoagulation therapy for atrial fibrillation: Are we failing our patients? Can Fam Physician. 2017; 63(12): 943–4. 

Wakelin S. Primary-care overprescribing of rivaroxaban in patients without atrial fibrillation. Clinical Pharmacist. 2021; 10(1): 1. DOI: https://doi.org/10.1211/PJ.2017.20204043 

Garasto S, Fusco S, Onder G, et al. Inappropriate prescription of low molecular weight heparins for thromboprophylaxis among older hospitalized patients. Aging Clinical and Experimental Research. 2017; 29(3): 483–90. DOI: https://doi.org/10.1007/s40520-016-0571-0 

Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999; 318(7182): 527–30. DOI: https://doi.org/10.1136/bmj.318.7182.527 

Kredo T, Bernhardsson S, Machingaidze S, et al. Guide to clinical practice guidelines: the current state of play. International Journal for Quality in Health Care. 2016; 28(1): 122–8. DOI: https://doi.org/10.1093/intqhc/mzv115 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372: n71. DOI: https://doi.org/10.1136/bmj.n71 

Murad MH. Clinical Practice Guidelines: A Primer on Development and Dissemination. Mayo Clin Proc. 2017; 92(3): 423-–33. DOI: https://doi.org/10.1016/j.mayocp.2017.01.001 

Clark JM, Sanders S, Carter M, et al. Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial. J Med Libr Assoc. 2020; 108(2): 195–207. DOI: https://doi.org/10.5195/jmla.2020.834 

Clark J, Glasziou P, Del Mar C, Bannach-Brown A, Stehlik P, Scott AM. A full systematic review was completed in 2 weeks using automation tools: a case study. Journal of Clinical Epidemiology. 2020; 121: 81–90. DOI: https://doi.org/10.1016/j.jclinepi.2020.01.008 

Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020; 368: l6890. DOI: https://doi.org/10.1136/bmj.l6890 

Hoy D, Brooks P, Woolf A, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. Journal of clinical epidemiology. 2012; 65(9): 934–9. DOI: https://doi.org/10.1016/j.jclinepi.2011.11.014 

Admassie E, Chalmers L, Bereznicki LR. Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation. American Journal of Cardiology. 2017; 120(7): 1133–8. DOI: https://doi.org/10.1016/j.amjcard.2017.06.055 

Moesker MJ, de Groot JF, Damen NL, et al. Guideline compliance for bridging anticoagulation use in vitamin-K antagonist patients; practice variation and factors associated with non-compliance. Thrombosis Journal [Electronic Resource]. 2019; 17: 15. DOI: https://doi.org/10.1186/s12959-019-0204-x 

Vesa SC, Vlaicu SI, Sabin O, et al. Evaluating Physician Adherence to Antithrombotic Recommendations in Patients with Atrial Fibrillation: A Pathway to Better Medical Education. International Journal of Environmental Research & Public Health [Electronic Resource]. 2020; 17(11): 04. DOI: https://doi.org/10.3390/ijerph17114008 

Wertheimer G, Bereznicki LR. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia. Journal of Cardiovascular Pharmacology & Therapeutics. 2019; 24(1): 46–53. DOI: https://doi.org/10.1177/1074248418786264 

Wong CX, Lee SW, Gan SW, et al. Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous Australians. Int J Cardiol. 2015; 191: 20-4. DOI: https://doi.org/10.1016/j.ijcard.2015.03.064 

Gorczyca I, Jelonek O, Michalska A, Chrapek M, Wałek P, Wożakowska-Kapłon B. Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience. Medicine (Baltimore). 2020; 99(29): e21209–e. DOI: https://doi.org/10.1097/MD.0000000000021209 

Khatib R, Nitti K, McDowell M, et al. Outpatient management of patients presenting with venous thromboembolism: Retrospective cohort study at 11 community hospitals. J Thromb Thrombolysis. 2021; 52(1): 179–88. DOI: https://doi.org/10.1007/s11239-020-02328-9 

Manoucheri R, Fallahi MJ. Adherence to Venous Thromboprophylaxis Guidelines for Medical and Surgical Inpatients of Teaching Hospitals, Shiraz-Iran. Tanaffos. 2015; 14(1): 17–26. 

Rossignol Y, Huet O, Chapalain X, et al. Compliance with the European trauma guidelines: An observational single centre study. Transfus Clin Biol. 2019; 26(1): 18–26. DOI: https://doi.org/10.1016/j.tracli.2018.05.002 

Steib A, Mertes PM, Marret E, Albaladejo P, Fusciardi J. Compliance with guidelines for the perioperative management of vitamin K antagonists. Thromb Res. 2014; 133(6): 1056–60. DOI: https://doi.org/10.1016/j.thromres.2014.03.053 

Waechter C, Ausbuettel F, Chatzis G, et al. Analysis of Atrial Fibrillation Treatment Regimes in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients. Journal of Interventional Cardiology. 2020; 2020: 6542028. DOI: https://doi.org/10.1155/2020/6542028 

Lauffenburger JC, Farley JF, Gehi AK, Rhoney DH, Brookhart MA, Fang G. Factors driving anticoagulant selection in patients with atrial fibrillation in the United States. The American Journal of Cardiology. 2015; 115(8): 1095–101. DOI: https://doi.org/10.1016/j.amjcard.2015.01.539 

Leblanc K, Bell AD, Ezekowitz JA, et al. Non-vitamin K antagonist oral anticoagulant (NOAC) use and dosing in Canadian practice: Insights from the optimising pharmacotherapy in the management approach to lowering risk in atrial fibrillation (OPTIMAL AF) Programme. Int J Clin Pract. 2020; 74(12): e13625. DOI: https://doi.org/10.1111/ijcp.13625 

Miyazawa K, Ogawa H, Mazurek M, et al. Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries. Circulation Journal. 2019; 83(12): 2434–42. DOI: https://doi.org/10.1253/circj.CJ-19-0546 

Boivin-Proulx LA, Deneault-Marchand A, Matteau A, et al. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry. Clinical Cardiology. 2020; 43(3): 216–21. DOI: https://doi.org/10.1002/clc.23316 

Devine EB, Hopefl AW, Wittkowsky AK. Adherence to guidelines for the management of excessive warfarin anticoagulation. J Thromb Thrombolysis. 2009; 27(4): 379–84. DOI: https://doi.org/10.1007/s11239-008-0232-z 

Giustozzi M, Agnelli G, Quattrocchi S, et al. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation. Cerebrovascular Diseases Extra. 2020; 10(2): 44–9. DOI: https://doi.org/10.1159/000506923 

Jortveit J, Pripp AH, Langørgen J, Halvorsen S. Poor adherence to guideline recommendations among patients with atrial fibrillation and acute myocardial infarction. Eur J Prev Cardiol. 2019; 26(13): 1373–82. DOI: https://doi.org/10.1177/2047487319841940 

Moerlie AR, Van Uden RC, Mantel-Teeuwisse AK, Van Den Bemt P, Becker ML. Inpatient prescribing of dual antiplatelet therapy according to the guidelines: A prospective intervention study. Pharmacy Practice. 2020; 18(2): 1–6. DOI: https://doi.org/10.18549/PharmPract.2020.2.1803 

Uzieblo-Zyczkowska B, Krzesinski P, Maciorowska M, et al. Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) Registry. Cardiovascular Diagnosis & Therapy. 2021; 11(1): 14–27. DOI: https://doi.org/10.21037/cdt-20-839 

Vanbeselaere V, Truyers C, Elli S, et al. Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study. BMC Cardiovasc Disord. 2016; 16: 61. DOI: https://doi.org/10.1186/s12872-016-0235-1 

Gasson J, Blockman M, Willems B. Antibiotic prescribing practice and adherence to guidelines in primary care in the Cape Town Metro District, South Africa. Samj, S. 2018; 108(4): 304–10. DOI: https://doi.org/10.7196/SAMJ.2017.v108i4.12564 

Devereaux PJ, Anderson DR, Gardner MJ, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ. 2001; 323(7323): 1218–22. DOI: https://doi.org/10.1136/bmj.323.7323.1218 

Proietti M, Lane DA, Boriani G, Lip GYH. Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines. Can J Cardiol. 2019; 35(5): 619–33. DOI: https://doi.org/10.1016/j.cjca.2019.02.009 

Gupta A, Lindstrom S, Shevatekar G. Reducing Opioid Overprescribing by Educating, Monitoring and Collaborating with Clinicians: A Quality Improvement Study. Cureus. 2020; 12(4): e7778–e. DOI: https://doi.org/10.7759/cureus.7778 

Abookire SA, Karson AS, Fiskio J, Bates DW. Use and monitoring of ‘statin’ lipid-lowering drugs compared with guidelines. Arch Intern Med. 2001; 161(1): 53–8. DOI: https://doi.org/10.1001/archinte.161.1.53 

Hosking SM, Etherton-Beer C, Page AT. Undiagnosing: Correcting the medical record to prevent over-intervention. Case Rep Womens Health. 2019; 23: e00133–e. DOI: https://doi.org/10.1016/j.crwh.2019.e00133 

Mitchell A, Snowball J, Welsh TJ, Watson MC, McGrogan A. Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study. BMC Medicine. 2021; 19(1): 189. DOI: https://doi.org/10.1186/s12916-021-02067-5 

Hanley JP. Warfarin reversal. J Clin Pathol. 2004; 57(11): 1132–9. DOI: https://doi.org/10.1136/jcp.2003.008904 

Harrison R, Hinchcliff RA, Manias E, et al. Can feedback approaches reduce unwarranted clinical variation? A systematic rapid evidence synthesis. BMC Health Services Research. 2020; 20(1): 40. DOI: https://doi.org/10.1186/s12913-019-4860-0 

Ho KH, van Hove M, Leng G. Trends in anticoagulant prescribing: a review of local policies in English primary care. BMC Health Services Research. 2020; 20(1): 279. DOI: https://doi.org/10.1186/s12913-020-5058-1 

Tomson CRV, van der Veer SN. Learning from practice variation to improve the quality of care. Clin Med (Lond). 2013; 13(1): 19–23. DOI: https://doi.org/10.7861/clinmedicine.13-1-19 

Iannone P, Montano N, Minardi M, Doyle J, Cavagnaro P, Cartabellotta A. Wrong guidelines: why and how often they occur. Evidence Based Medicine. 2017; 22(1): 1. DOI: https://doi.org/10.1136/ebmed-2016-110606 

McAlister FA, van Diepen S, Padwal RS, Johnson JA, Majumdar SR. How evidence-based are the recommendations in evidence-based guidelines? PLoS Med. 2007; 4(8): e250–e. DOI: https://doi.org/10.1371/journal.pmed.0040250 

Hughes LD, McMurdo ME, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2013; 42(1): 62–9. DOI: https://doi.org/10.1093/ageing/afs100 

Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010; 123(7): 638–45.e4. DOI: https://doi.org/10.1016/j.amjmed.2009.11.025 

Haas S, Ageno W, Weitz JI, et al. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients. Journal of Thrombosis & Haemostasis. 2019; 17(10): 1694–706. DOI: https://doi.org/10.1111/jth.14548 

Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014; 11(11): 639–54. DOI: https://doi.org/10.1038/nrcardio.2014.118 

Brownlee S, Chalkidou K, Doust J, et al. Evidence for overuse of medical services around the world. Lancet. 2017; 390(10090): 156–68. DOI: https://doi.org/10.1016/S0140-6736(16)32585-5 

Salmasi S, Loewen PS, Tandun R, Andrade JG, De Vera MA. Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies. BMJ Open. 2020; 10(4): e034778. DOI: https://doi.org/10.1136/bmjopen-2019-034778 

Uhlig K, Leff B, Kent D, et al. A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity. J Gen Intern Med. 2014; 29(4): 670–9. DOI: https://doi.org/10.1007/s11606-013-2659-y 

Volovici V, Steyerberg EW, Cnossen MC, et al. Evolution of Evidence and Guideline Recommendations for the Medical Management of Severe Traumatic Brain Injury. J Neurotrauma. 2019; 36(22): 3183–9. DOI: https://doi.org/10.1089/neu.2019.6474 

Jia P, Zhang L, Chen J, Zhao P, Zhang M. The Effects of Clinical Decision Support Systems on Medication Safety: An Overview. PLoS One. 2016; 11(12): e0167683–e. DOI: https://doi.org/10.1371/journal.pone.0167683 

Koesmahargyo V, Abbas A, Zhang L, et al. Accuracy of machine learning-based prediction of medication adherence in clinical research. Psychiatry Research. 2020; 294: 113558. DOI: https://doi.org/10.1016/j.psychres.2020.113558 

Su L, Liu C, Li D, et al. Toward Optimal Heparin Dosing by Comparing Multiple Machine Learning Methods: Retrospective Study. JMIR Med Inform. 2020; 8(6): e17648–e. DOI: https://doi.org/10.2196/17648 

Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digital Medicine. 2020; 3(1): 17. DOI: https://doi.org/10.1038/s41746-020-0221-y 

Ru X, Zhu L, Ma Y, Wang T, Pan Z. Effect of an artificial intelligence-assisted tool on non-valvular atrial fibrillation anticoagulation management in primary care: protocol for a cluster randomized controlled trial. Trials. 2022; 23(1): 316. DOI: https://doi.org/10.1186/s13063-022-06250-8 

Kwan JL, Lo L, Ferguson J, et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ. 2020; 370: m3216. DOI: https://doi.org/10.1136/bmj.m3216